🔎 Trials Near Me

Início › Câncer (todos os tipos) › Texas › Houston

Ensaios clínicos de Câncer (todos os tipos) em Houston, TX

121 estudos para Câncer (todos os tipos) estão buscando participantes em locais em Houston e arredores (num raio de aproximadamente 30 milhas). Abra um estudo para ver quem pode participar e como contatar a equipe.

Texto oficial do estudo (Inglês)

Recrutando participantes para um estudo? Destaque-o no topo desta página — $99 por 30 dias →

A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma

RecrutandoFase 1
  • The University of Texas - MD Anderson Cancer Center, Houston
Idades 18 e acima · Todos os sexos · Atualizado em 30 de set. de 2026 · NCT07192471

uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto

RecrutandoEstudo observacional
  • The University of Texas M.D. Anderson Cancer Center, Houston
Idades 18 e acima · Todos os sexos · Atualizado em 29 de set. de 2026 · NCT05874921

A Study of PHN-012 in Patients With Advanced Solid Tumors

RecrutandoFase 1
  • PHN-012-001 Site, Houston
Idades 18 e acima · Todos os sexos · Atualizado em 29 de set. de 2026 · NCT07127874

A Phase 3 Study of Ersodetug in Patients With Tumor Hyperinsulinism

RecrutandoFase 3
  • Investigative Site, Houston
Idades 18 e acima · Todos os sexos · Atualizado em 28 de set. de 2026 · NCT06881992

A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)

RecrutandoFase 3
  • Oncology Consultants PA, Houston
  • University of Texas MD Anderson Cancer Center, Houston
Idades de 18 a 100 · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT05920356

A Study of JNJ-1761981 in Participants With Solid Tumors

RecrutandoFase 1
  • MD Anderson Cancer Center, Houston
Idades 18 e acima · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT07525141

A Study of MK-5684 in People With Certain Solid Tumors (MK-5684-015/OMAHA-015)

RecrutandoFase 2
  • Baylor College of Medicine Medical Center ( Site 0004), Houston
  • Harris Health System ( Site 0040), Houston
Idades 18 e acima · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT06979596

A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue

RecrutandoFase 2/3
  • Houston Methodist Hospital, Houston
Idades 18 e acima · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT06989437

A Study of JNJ-87704916, as Monotherapy and in Combination for Advanced Solid Tumors

RecrutandoFase 1
  • MD Anderson Cancer Center, Houston
Idades 18 e acima · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT06311578

A Study of NEOK001, a B7-H3 and ROR1 Targeting Bispecific ADC in Participants With Select Solid Tumors

RecrutandoFase 1
  • MD Anderson Cancer Center, Houston
  • NEXT Oncology, Houston
Idades 18 e acima · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT07612176

A Study of Ifinatamab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01D/LIGHTBEAM-U01)

RecrutandoFase 1/2
  • University of Texas M.D. Anderson Cancer Center ( Site 4007), Houston
1 Month – 17 Years · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT07630974

A Study of JNJ-88549968 for the Treatment of Calreticulin (CALR)-Mutated Myeloproliferative Neoplasms

RecrutandoFase 1
  • MD Anderson Cancer Center, Houston
Idades 18 e acima · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT06150157

Pilot Study of Management of Facial Paralysis in the Oncologic Patient: Nerve Transfer Techniques to Improve Facial Function and Quality of Life

Recrutando
  • The University of Texas M. D. Anderson Cancer Center, Houston
Idades 18 e acima · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT06667427

A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer

RecrutandoFase 3
  • Houston Methodist Cancer Center, Houston
Idades 18 e acima · Todos os sexos · Atualizado em 24 de set. de 2026 · NCT06901531

Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia

RecrutandoFase 3
  • Quetzal Site 6, Houston
Idades de 18 a 71 · Todos os sexos · Atualizado em 23 de set. de 2026 · NCT07504458

Intratumoral N17350 in Advanced Solid Tumors

RecrutandoFase 1/2
  • The University of Texas MD Anderson Cancer Center, Houston
Idades 18 e acima · Todos os sexos · Atualizado em 23 de set. de 2026 · NCT07339176

A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer

RecrutandoFase 3
  • The University of Texas MD Anderson Cancer Center /ID# 280070, Houston
Idades 18 e acima · Todos os sexos · Atualizado em 23 de set. de 2026 · NCT07365241

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

RecrutandoFase 1/2
  • MD Anderson, Houston
Idades 18 e acima · Todos os sexos · Atualizado em 22 de set. de 2026 · NCT06128551

TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer

RecrutandoFase 2
  • The University of Texas MD Anderson Cancer Center, Houston
Idades 12 e acima · Todos os sexos · Atualizado em 22 de set. de 2026 · NCT02693535

Bone Marrow Imaging and Clinical Outcomes Across Hematologic, Oncologic, and Other Relevant Conditions

RecrutandoEstudo observacional
  • UT MD Anderson Cancer Center, Houston
Todas as idades · Todos os sexos · Atualizado em 18 de set. de 2026 · NCT07743476

Perceptions of Hospital Care at Home for Patients With Cancer: A Qualitative Study of Cancer Providers, Patients and Caregivers.

RecrutandoEstudo observacional
  • M D Anderson Cancer Center, Houston
Idades 18 e acima · Todos os sexos · Atualizado em 18 de set. de 2026 · NCT05694650

Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells

RecrutandoFase 2/3
  • The University of Texas Health Science Center at Houston, Houston
  • University of Texas- MD Anderson, Houston
Todas as idades · Todos os sexos · Atualizado em 18 de set. de 2026 · NCT03435796

A Study of Patritumab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01C/LIGHTBEAM-U01)

RecrutandoFase 1/2
  • University of Texas-MD Anderson Cancer Center ( Site 3007), Houston
1 Month – 17 Years · Todos os sexos · Atualizado em 17 de set. de 2026 · NCT06941272

Statins to Prevent Cancer Associated Blood Clots

RecrutandoFase 4
  • The University of Texas MD Anderson Cancer Center, Houston
Idades 18 e acima · Todos os sexos · Atualizado em 16 de set. de 2026 · NCT07303816

(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis

RecrutandoFase 2
  • The University of Texas MD Anderson Cancer Center, Houston
Idades 18 e acima · Todos os sexos · Atualizado em 15 de set. de 2026 · NCT04996875

Treatment of Immune Checkpoint Inhibitor-related Diarrhea and/ or Colitis With Ustekinumab in Cancer Patients

RecrutandoFase 2
  • The University of Texas M. D. Anderson Cancer Center, Houston
Idades 18 e acima · Todos os sexos · Atualizado em 14 de set. de 2026 · NCT06807593

A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies

RecrutandoFase 1/2
  • Research Site, Houston
Idades 18 e acima · Todos os sexos · Atualizado em 11 de set. de 2026 · NCT05123482

A Clinical Study of MK-8294 in Participants With Advanced Solid Tumors (MK-8294-001)

RecrutandoFase 1
  • Houston Methodist Hospital ( Site 0103), Houston
Idades 18 e acima · Todos os sexos · Atualizado em 11 de set. de 2026 · NCT07030712

A Study to Investigate Safety and Effectiveness of Tacabrutideg (BGB-16673) in Combination With Other Agents in Participants With Relapsed or Refractory B-Cell Malignancies

RecrutandoFase 1/2
  • The University of Texas Md Anderson Cancer Center, Houston
Idades 18 e acima · Todos os sexos · Atualizado em 11 de set. de 2026 · NCT06634589

A Study to Evaluate the Safety and Efficacy of MK-3120 in Participants With Advanced Solid Tumors (MK-3120-002)

RecrutandoFase 1/2
  • NEXT Oncology ( Site 1011), Houston
Idades 18 e acima · Todos os sexos · Atualizado em 10 de set. de 2026 · NCT06818643

Safety, Pharmacokinetics, and Preliminary Efficacy of VIR-5500 (AMX-500) in Prostate Cancer

RecrutandoFase 1
  • Investigational Site Number: 401, Houston
Idades 18 e acima · Homens · Atualizado em 10 de set. de 2026 · NCT05997615

A Phase 1/1b Study of IAM1363 in HER2 Cancers

RecrutandoFase 1
  • MD Anderson Cancer Center - University of Texas, Houston
Idades 18 e acima · Todos os sexos · Atualizado em 9 de set. de 2026 · NCT06253871

A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors

RecrutandoFase 1
  • UT MD Anderson, Houston
Idades 18 e acima · Todos os sexos · Atualizado em 9 de set. de 2026 · NCT06440005

Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer

RecrutandoFase 1/2
  • University of Texas MD Anderson Cancer Center, Houston
Idades 18 e acima · Todos os sexos · Atualizado em 9 de set. de 2026 · NCT05386108

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

RecrutandoFase 3
  • Houston Methodist Hospital, Houston
  • University of Texas MD Anderson Cancer Center, Houston
  • Lumi Research, Houston
Idades 18 e acima · Todos os sexos · Atualizado em 8 de set. de 2026 · NCT06119581

HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors

RecrutandoFase 1
  • MD Anderson Cancer Center, Houston
36 Months – 22 Years · Todos os sexos · Atualizado em 4 de set. de 2026 · NCT03911388

Cytotoxic T Lymphocytes in Treating Patients With Malignancies With BK and/or JC Virus

RecrutandoFase 2
  • M D Anderson Cancer Center, Houston
Todas as idades · Todos os sexos · Atualizado em 4 de set. de 2026 · NCT02479698

A Study to Evaluate LY3537021 for the Treatment of Nausea and Vomiting Caused by Chemotherapy in Adults With Cancer

RecrutandoFase 2
  • Kelsey-Seybold Clinic, Houston
Idades 18 e acima · Todos os sexos · Atualizado em 4 de set. de 2026 · NCT07169851

A Study of ERAS-0015 in Patients With Advanced or Metastatic Solid Tumors

RecrutandoFase 1
  • The University of Texas MD Anderson Cancer Center, Houston
Idades de 18 a 99 · Todos os sexos · Atualizado em 1 de set. de 2026 · NCT06983743

PREDICTT Clinical Trial: Prospective Evaluation Of Pressure-Enabled Delivery And Alterations In CT-Based Tumor-To-Normal Liver Ratio And Tumor Dose Using The Trinav Infusion System

Recrutando
  • The University of Texas M. D. Anderson Cancer Center, Houston
Idades 18 e acima · Todos os sexos · Atualizado em 1 de set. de 2026 · NCT07444645

Phase 2 Trial of Obinutuzumab and CC-99282 for Patients With Previously Untreated High Tumor Burden Follicular Lymphoma

RecrutandoFase 2
  • M D Anderson Cancer Center, Houston
Idades 18 e acima · Todos os sexos · Atualizado em 31 de ago. de 2026 · NCT06108232

ORB-021 In Patients With Advanced Solid Tumors

RecrutandoFase 1
  • MDAC, Houston
Idades 18 e acima · Todos os sexos · Atualizado em 26 de ago. de 2026 · NCT06607939

Project: Every Child for Younger Patients With Cancer

RecrutandoEstudo observacional
  • Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center, Houston
  • UT MD Anderson Cancer Center, Houston
Até 25 anos · Todos os sexos · Atualizado em 25 de ago. de 2026 · NCT02402244

Efficacy and Safety of Intravesical TARA-002 Compared With Investigator's Choice of Intravesical Chemotherapy in Participants With BCG-naïve High-grade Non-muscle Invasive Bladder Cancer

RecrutandoFase 3
  • Houston Metro Urology, Houston
Idades 18 e acima · Todos os sexos · Atualizado em 21 de ago. de 2026 · NCT07480356

Abatacept in Immune Checkpoint Inhibitor Myocarditis

RecrutandoFase 3
  • MD Anderson Cancer Center, Houston
Idades 18 e acima · Todos os sexos · Atualizado em 20 de ago. de 2026 · NCT05335928

FOG-001 in Locally Advanced or Metastatic Solid Tumors

RecrutandoFase 1/2
  • The University of Texas MD Anderson Cancer Center, Houston
Idades 18 e acima · Todos os sexos · Atualizado em 17 de ago. de 2026 · NCT05919264

Psycho-Spiritual Management for Patients With Advanced Cancer and Their Family Caregivers

Recrutando
  • MD Anderson, Houston
Idades 18 e acima · Todos os sexos · Atualizado em 14 de ago. de 2026 · NCT06409065

Development of Brief Positive Affect Treatment (PAT) for Caregivers of Patients With Advanced Cancer

RecrutandoEstudo observacional
  • The University of Texas M. D. Anderson Cancer Center, Houston
Idades 18 e acima · Todos os sexos · Atualizado em 14 de ago. de 2026 · NCT05904782

Phase 1 Study of JV-394 Autologous Anti-CD94 CAR T for r/r CD94+ T/NK Cell Neoplasms

RecrutandoFase 1
  • The University of Texas M. D. Anderson Cancer Center, Houston
Idades 18 e acima · Todos os sexos · Atualizado em 12 de ago. de 2026 · NCT07382817

TRIPS - Treatment to Improve Depression and/or Anxiety Using Psilocybin-assisted Psychotherapy in Cancer Survivors

RecrutandoFase 2
  • The University of Texas M. D. Anderson Cancer Center, Houston
Idades 18 e acima · Todos os sexos · Atualizado em 12 de ago. de 2026 · NCT06801041

Cancer-related Fatigue and Its Biological Contributors in Adolescent and Young Adult Brain Tumor Survivors: Effects of a Tele-exercise Intervention

Recrutando
  • The University of Texas M. D. Anderson Cancer Center, Houston
Idades de 18 a 39 · Todos os sexos · Atualizado em 12 de ago. de 2026 · NCT07186556

A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors

RecrutandoFase 1/2
  • The University of Texas, MD Anderson Cancer Center, Houston
Idades 18 e acima · Todos os sexos · Atualizado em 11 de ago. de 2026 · NCT05592626

Evaluation of the Response and Non-response of Nirogacestat in Desmoid Tumors- Clinical Study

RecrutandoFase 2
  • M D Anderson Cancer Center, Houston
Idades 18 e acima · Todos os sexos · Atualizado em 10 de ago. de 2026 · NCT05879146

Examining the Feasibility and Impact of a Clinic-based Food Farmacy and Digital Culinary Medicine Program Among Cancer Survivors Treated in a Safety Net Hospital

Recrutando
  • The University of Texas M. D. Anderson Cancer Center, Houston
Idades 18 e acima · Todos os sexos · Atualizado em 10 de ago. de 2026 · NCT06760754

A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With Cancer

RecrutandoFase 2
  • Texas Childrens Hospital, Houston
  • University of Texas MD Anderson Cancer Center, Houston
Idades de 1 a 39 · Todos os sexos · Atualizado em 7 de ago. de 2026 · NCT05999994

Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer

RecrutandoFase 3
  • Houston Methodist Hospital, Houston
  • Memorial Hermann Texas Medical Center, Houston
  • Methodist Willowbrook Hospital, Houston
  • e mais 1
Idades 18 e acima · Todos os sexos · Atualizado em 7 de ago. de 2026 · NCT06580314

IDOV-Immune for Advanced Solid Tumors

RecrutandoFase 1
  • MD Anderson Cancer Center, Houston
Idades 18 e acima · Todos os sexos · Atualizado em 5 de ago. de 2026 · NCT06910657

New Assessment System in Measuring Symptom Distress in Cancer Patients

RecrutandoEstudo observacionalVoluntários saudáveis bem-vindos
  • M D Anderson Cancer Center, Houston
Idades 18 e acima · Todos os sexos · Atualizado em 29 de jul. de 2026 · NCT00505245

Selpercatinib Pre-RAI in Patients With RET Fusion Thyroid Cancer (RAISE)

RecrutandoFase 2
  • MD Anderson Cancer Center, Houston
Idades de 2 a 25 · Todos os sexos · Atualizado em 24 de jul. de 2026 · NCT06458036

Testing eSCCIP: An eHealth Psychosocial Intervention for English and Spanish Speaking Parents of Children With Cancer

RecrutandoVoluntários saudáveis bem-vindos
  • MD Anderson Cancer Center, Houston
Todas as idades · Todos os sexos · Atualizado em 17 de jul. de 2026 · NCT05294302

Decoupling Immunotherapy Toxicity and Cancer Response

RecrutandoEstudo observacional
  • The University of Texas M. D. Anderson Cancer Center, Houston
Idades 18 e acima · Todos os sexos · Atualizado em 16 de jul. de 2026 · NCT07382752

A Randomized Controlled Trial of Inhaled Tranexamic Acid for the Treatment of Pulmonary Hemorrhage in Cancer Patients

RecrutandoFase 3
  • M D Anderson Cancer Center, Houston
Idades 18 e acima · Todos os sexos · Atualizado em 16 de jul. de 2026 · NCT05053867

Association Between Health Care Provider (HCP)-Assessed ECOG Performance Status (PS) and Overall Survival, and Objectively Measure of Physical Activity (PA) Levels in Advance-cancer Patients"

Recrutando
  • M D Anderson Cancer Center, Houston
Idades 18 e acima · Todos os sexos · Atualizado em 15 de jul. de 2026 · NCT01365169

Long-Term Follow-Up of Recipient of Gene Transfer Research

RecrutandoEstudo observacionalVoluntários saudáveis bem-vindos
  • University of Texas MD Anderson Cancer Center, Houston
Todas as idades · Todos os sexos · Atualizado em 15 de jul. de 2026 · NCT01492036

A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma

RecrutandoFase 1
  • Oncology Consultants /ID# 268323, Houston
Idades 18 e acima · Todos os sexos · Atualizado em 13 de jul. de 2026 · NCT05650632

First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors

RecrutandoFase 1/2
  • University of Texas MD Anderson Cancer Center, Houston
Idades 18 e acima · Todos os sexos · Atualizado em 7 de jul. de 2026 · NCT05768139

A Clinical Study to Test if an Investigational Treatment Called BNT314 When Used in Combination With Another Investigational Treatment Pumitamig (BNT327) and Chemotherapy, is Beneficial and Safe for Patients With Advanced Colorectal Cancer

RecrutandoFase 1/2
  • The University of Texas MD Anderson Cancer Center, Houston
Idades 18 e acima · Todos os sexos · Atualizado em 1 de jul. de 2026 · NCT07079631

Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC

RecrutandoFase 1/2
  • The University of Texas MD Anderson Cancer Center, Houston
Idades 18 e acima · Todos os sexos · Atualizado em 30 de jun. de 2026 · NCT06162221

Molecular Genetics Studies of Cancer Patients and Their Relatives

RecrutandoEstudo observacionalVoluntários saudáveis bem-vindos
  • Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center, Houston
Todas as idades · Todos os sexos · Atualizado em 29 de jun. de 2026 · NCT04185935

Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors

RecrutandoFase 1/2
  • The University of Texas MD Anderson Cancer Center, Houston
Idades 18 e acima · Todos os sexos · Atualizado em 23 de jun. de 2026 · NCT06993844

A Multi Center Study of Sexual Toxicities After Radiotherapy

RecrutandoEstudo observacional
  • M.D. Anderson Cancer Center, Houston
Idades 18 e acima · Mulheres · Atualizado em 22 de jun. de 2026 · NCT05394428

Childhood Cancer Survivor Study

RecrutandoEstudo observacionalVoluntários saudáveis bem-vindos
  • M.D. Anderson Cancer Center, Houston
  • Texas Children's Hospital, Houston
Todas as idades · Todos os sexos · Atualizado em 17 de jun. de 2026 · NCT01120353

Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI

Recrutando
  • Michael E. DeBakey VA Medical Center, Houston, TX, Houston
Idades de 18 a 75 · Todos os sexos · Atualizado em 17 de jun. de 2026 · NCT05486572

A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations

RecrutandoFase 1
  • Research Site, Houston
Idades 18 e acima · Todos os sexos · Atualizado em 10 de jun. de 2026 · NCT06835569

Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors

RecrutandoFase 1
  • University of Texas MD Anderson Cancer Center /ID# 252004, Houston
Idades 18 e acima · Todos os sexos · Atualizado em 4 de jun. de 2026 · NCT04777994

A Phase 1/1B Study of ST-01156, a Small Molecule RBM39 Degrader, in Patients With Advanced Solid Malignancies

RecrutandoFase 1
  • The University of Texas MD Anderson Cancer Center, Houston
Idades 16 e acima · Todos os sexos · Atualizado em 2 de jun. de 2026 · NCT07197554

Active Living After Cancer: Implementation Within Be Well Acres Homes

Recrutando
  • The University of Texas M. D. Anderson Cancer Center, Houston
Idades 18 e acima · Todos os sexos · Atualizado em 1 de jun. de 2026 · NCT06907706

A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements

RecrutandoFase 1/2
  • MD Anderson Cancer Center, Houston
Idades 12 e acima · Todos os sexos · Atualizado em 27 de mai. de 2026 · NCT03093116

ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors

RecrutandoFase 1/2
  • University of Texas MD Anderson Cancer Center, Houston
Idades 18 e acima · Todos os sexos · Atualizado em 13 de mai. de 2026 · NCT03686124

A First-in-Human (FIH) Study to Evaluate the Safety and Tolerability of VVD-130037 in Participants With Advanced Solid Tumors

RecrutandoFase 1
  • MDACC, Houston
Idades 18 e acima · Todos os sexos · Atualizado em 8 de mai. de 2026 · NCT05954312

Neoadjuvant PD-1 Plus TIGIT Blockade in Patients With Cisplatin-Ineligible Operable High-Risk Urothelial Carcinoma

RecrutandoFase 1/2
  • M D Anderson Cancer Center, Houston
Idades 18 e acima · Todos os sexos · Atualizado em 5 de mai. de 2026 · NCT05394337

Combination Therapy for Cancer Related Fatigue in Patients With Metastatic Cancers

RecrutandoFase 2/3
  • MD Anderson Cancer Centerr, Houston
Idades 18 e acima · Todos os sexos · Atualizado em 5 de mai. de 2026 · NCT06085716

A Study to Evaluate the Efficacy and Safety of TL118 in Solid Tumors Patients

RecrutandoFase 2
  • The University of Texas MD Anderson Cancer Center, Houston
Idades 18 e acima · Todos os sexos · Atualizado em 28 de abr. de 2026 · NCT06010342

A Study of TSN1611 Treating Patients With Advanced Solid Tumors Harboring KRAS G12D Mutation

RecrutandoFase 1/2
  • MD Anderson Cancer Center, Houston
Idades de 18 a 75 · Todos os sexos · Atualizado em 24 de abr. de 2026 · NCT06385925

A Study to Evaluate the Efficacy and Safety of Sutetinib Maleate Capsule in Locally Advanced or Metastatic NSCLC

RecrutandoFase 2
  • University of Texas MD Anderson Cancer Center, Houston
Idades 18 e acima · Todos os sexos · Atualizado em 24 de abr. de 2026 · NCT06010329

Assessment of Functional and Symptom Outcomes for Survivors of Paranasal Sinus, Nasopharyngeal and Skull Base Tumors

RecrutandoEstudo observacional
  • M D Anderson Cancer Center, Houston
Idades 18 e acima · Todos os sexos · Atualizado em 21 de abr. de 2026 · NCT05733091

A Study to Investigate the Safety and Efficacy of NST-628 Oral Tablets in Subjects With Solid Tumors

RecrutandoFase 1
  • MD Anderson Cancer Center, Houston
Idades 18 e acima · Todos os sexos · Atualizado em 20 de abr. de 2026 · NCT06326411

Validation of the Screen of Cancer Survivorship - Occupational Therapy Services (SOCS-OTS) Tool for Use in a Physical Medicine Rehabilitation Clinic

RecrutandoEstudo observacional
  • MD Anderson Cancer Center, Houston
Idades 18 e acima · Todos os sexos · Atualizado em 16 de abr. de 2026 · NCT06329531

CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)

RecrutandoFase 1/2
  • The University of Texas MD Anderson Cancer Center, Houston
Idades 18 e acima · Todos os sexos · Atualizado em 16 de abr. de 2026 · NCT03328078

Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of TGW101 in Participants With Advanced Solid Tumors

RecrutandoFase 1
  • University of Texas MD Anderson Cancer Center, Houston
Idades 18 e acima · Todos os sexos · Atualizado em 16 de abr. de 2026 · NCT06959706

Phase II Study of Pembrolizumab in Combination With Lenvatinib in Patients With TNBC, NSCLC, and Other Tumor Types and Brain Metastases

RecrutandoFase 2
  • M D Anderson Cancer Center, Houston
Idades 18 e acima · Todos os sexos · Atualizado em 16 de abr. de 2026 · NCT05064280

The Cancer Stage Shifting Initiative: Registry and Biorepository to Research and Address Health Disparities in Cancer Care

RecrutandoEstudo observacionalVoluntários saudáveis bem-vindos
  • Grace Clinic, Houston
Idades 35 e acima · Todos os sexos · Atualizado em 8 de abr. de 2026 · NCT07461493

Suprachoroidal Administration in Subjects With Metastases to the Choroid

RecrutandoFase 2
  • Retina Consultants of Texas, Bellaire · a 7 mi de distância
Idades 18 e acima · Todos os sexos · Atualizado em 13 de mar. de 2026 · NCT06643884

Comprehensive Multimodal Prehabilitation Alone or With Neoadjuvant Therapy Before Major Cancer Surgery

RecrutandoFase 2
  • Houston Methodist Neal Cancer Center, Houston
Idades 18 e acima · Todos os sexos · Atualizado em 12 de mar. de 2026 · NCT07050771

The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study

RecrutandoEstudo observacional
  • Md Anderson Cancer Center, Houston
Idades 18 e acima · Todos os sexos · Atualizado em 5 de mar. de 2026 · NCT04075305

Effectiveness and Performance of an Optical Biopsy Technology for Esophageal Cancer in Brazil and the United States

RecrutandoFase 2
  • Baylor St. Luke's Medical Center, Houston
  • Ben Taub Hospital (Harris Health Systems), Houston
Idades 18 e acima · Todos os sexos · Atualizado em 2 de mar. de 2026 · NCT06435286

Cultural Tailoring and Pilot Testing of an Inpatient Yoga Therapy Program for Cancer Patients Undergoing Hematopoietic Stem Cell Transplantation in India, Tanzania, and the United States

Recrutando
  • M D Anderson Cancer Center, Houston
Idades 18 e acima · Todos os sexos · Atualizado em 27 de fev. de 2026 · NCT05681026

Primary Tumor Research and Outcomes Network

RecrutandoEstudo observacional
  • The University of Texas M.D. Anderson Cancer Center, Houston
Todas as idades · Todos os sexos · Atualizado em 25 de fev. de 2026 · NCT02790983

Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy

Recrutando
  • Michael E. DeBakey VA Medical Center, Houston, TX, Houston
Idades 18 e acima · Todos os sexos · Atualizado em 19 de fev. de 2026 · NCT02984761

A Study of YL242 in Subjects With Advanced Solid Tumors

RecrutandoFase 1/2
  • US-203, Houston
Idades 18 e acima · Todos os sexos · Atualizado em 24 de dez. de 2025 · NCT07197827

Spiritual Care or Psychotherapy Versus Palliative Care Alone in Patients With Non-Curative Malignancies

RecrutandoFase 3
  • Houston Methodist Neal Cancer Center, Houston
Idades 18 e acima · Todos os sexos · Atualizado em 18 de dez. de 2025 · NCT07290491

A Study of ERAS-4001 in Patients With Advanced or Metastatic Solid Tumors.

RecrutandoFase 1
  • The University of Texas MD Anderson Cancer Center, Houston
Idades de 18 a 99 · Todos os sexos · Atualizado em 3 de dez. de 2025 · NCT07021898

Larotrectinib to Enhance RAI Avidity in Differentiated Thyroid Cancer

RecrutandoFase 2
  • MD Anderson Cancer Center, Houston
Idades de 2 a 99 · Todos os sexos · Atualizado em 14 de nov. de 2025 · NCT05783323

Targeted Therapy to Increase RAI Uptake in Metastatic DTC

RecrutandoEstudo observacional
  • MD Anderson Cancer Center, Houston
  • Texas Children's Hospital, Houston
Idades 0 e acima · Todos os sexos · Atualizado em 14 de nov. de 2025 · NCT05024929

Childhood Cancer Predisposition Study (CCPS)

RecrutandoEstudo observacional
  • Baylor College of Medicine, Houston
Todas as idades · Todos os sexos · Atualizado em 29 de out. de 2025 · NCT04511806

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

RecrutandoEstudo observacional
  • Massive Bio SYNERGY-AI site, Houston
Todas as idades · Todos os sexos · Atualizado em 28 de out. de 2025 · NCT03452774

A Prospective Registry to Enable Collection of Standardized Routine Care Oncology Patient Data

RecrutandoEstudo observacionalVoluntários saudáveis bem-vindos
  • Oncology Consultants, P.A., Houston
Idades de 18 a 120 · Todos os sexos · Atualizado em 20 de out. de 2025 · NCT06877884

Uterine Manipulation During Minimally Invasive Surgery for Early Stage Endometrial Cancer

Recrutando
  • Baylor College of Medicine- McNair Campus, Houston
  • Baylor College of Medicine, Houston
  • Ben Taub General Hospital, Houston
  • e mais 1
Idades de 18 a 90 · Mulheres · Atualizado em 15 de out. de 2025 · NCT04586959

Endoscopic Ultrasound Radiofrequency Ablation and Immunotherapy Pembrolizumab for Locally Advanced Unresectable and Metastatic Pancreatic Duct Adenocarcinoma

RecrutandoFase 2
  • The University of Texas Health Science Center at Houston, Houston
Idades 18 e acima · Todos os sexos · Atualizado em 10 de set. de 2025 · NCT06831136

A Study of NX-1607 in Adults With Advanced Malignancies

RecrutandoFase 1
  • MD Anderson Cancer Center, Houston
Idades 18 e acima · Todos os sexos · Atualizado em 9 de set. de 2025 · NCT05107674

A Study Assessing KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors

RecrutandoFase 1/2
  • MD Anderson Cancer Center, Houston
Idades 18 e acima · Todos os sexos · Atualizado em 18 de mai. de 2025 · NCT05970497

A Trial of AMXI-5001 for Treatment in Patients With Advanced Malignancies

RecrutandoFase 1/2
  • The University of Texas MD Anderson Cancer Center, Houston
Idades 18 e acima · Todos os sexos · Atualizado em 1 de mai. de 2025 · NCT04503265

Trial of DFP-14927 in Advanced Solid Tumors

RecrutandoFase 1
  • MD Anderson Cancer Center, Houston
Idades 18 e acima · Todos os sexos · Atualizado em 3 de mar. de 2025 · NCT03943004

A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies

RecrutandoFase 1/2
  • Oncology Consultants, P.A., Houston
  • The University of Texas M. D. Anderson Cancer Center, Houston
Idades 18 e acima · Todos os sexos · Atualizado em 13 de fev. de 2025 · NCT05669430

Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma

Recrutando
  • The University of Texas MD Anderson Cancer Center, Houston
Idades 18 e acima · Todos os sexos · Atualizado em 27 de nov. de 2024 · NCT03860883

HPV Vaccine, Imiquimod, and Metformin Combination Trial

RecrutandoFase 2
  • Baylor St. Luke's Medical Center- Dan L. Duncan Comprehensive Cancer Center, Houston
  • Harris Health Smith Clinic, Houston
Idades de 18 a 64 · Mulheres · Atualizado em 13 de nov. de 2024 · NCT06686043

A Study in Patients With Advanced Cancers

RecrutandoFase 1/2
  • University of Texas MD Anderson Cancer Center, Houston
Idades 18 e acima · Todos os sexos · Atualizado em 19 de jul. de 2022 · NCT05320588

Ensaios de Câncer (todos os tipos) em outras cidades

Outros estudos em Houston

Fonte: ClinicalTrials.gov, dados obtidos em 5 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.